Asarina Pharma Ab

Calculating rank

USPTO Granted Patents = 5

CIPO Patents = 7

EPO Patents = 2

Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

Torbjörn Bäckström (4 out of 16 patents)

Anders Carlsson (2 out of 22 patents)

Magnus Brisander (1 out of 23 patents)

4. Markus Jerling (1 out of 3 patents)

5. Karol Horvath (1 out of 1 patent)

6. Björn Norrlind (1 out of 2 patents)

7. Gianna Ragagnin (4 patents)

8. Anders Carlsson (0 patent)

9. Torbjorn Backstrom (0 patent)

10. Torbjoern Baeckstroem (0 patent)

5 patents: Sort by Forward Citations

1. 11534446 - Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties (2022-12-27),

2. 11026954 - 3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment (2021-06-08),

3. 11026953 - 3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor (2021-06-08),

4. 10933014 - Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof (2021-03-02),

5. 9687496 - Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties (2017-06-27),

Company Overview

Asarina Pharma is a Swedish biotech company focused on the development of novel treatments for women suffering from premenstrual dysphoric disorder (PMDD) and other hormone-related mood disorders. Their lead product candidate, Sepranolone, has shown promising results in clinical trials and has the potential to provide a much-needed treatment option for women experiencing severe PMDD symptoms.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#34 in Solna

#1,098 in Sweden

Solna, Sweden

Asarina Pharma Ab

Forward Citations = 1

6 inventors:

Torbjörn Bäckström (4 out of 16 patents)

Anders Carlsson (2 out of 22 patents)

Magnus Brisander (1 out of 23 patents)

4. Markus Jerling (1 out of 3 patents)

5. Karol Horvath (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Asarina Pharma Ab. Retrieved from https://idiyas.com/company/asarina-pharma-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]